These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 228696)

  • 41. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life.
    Bandy LC; Clarke-Pearson DL; Hammond CB
    Obstet Gynecol; 1984 Sep; 64(3):395-9. PubMed ID: 6087230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of endometrial curettage in the follow-up of hydatidiform mole.
    Flam F; Lundström V
    Acta Obstet Gynecol Scand; 1988; 67(7):649-51. PubMed ID: 3247837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trophoblastic disease: analysis of 342 patients.
    Nakano R; Sasaki K; Yamoto M; Hata H
    Gynecol Obstet Invest; 1980; 11(4):237-42. PubMed ID: 6256264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy.
    Burton JL; Lidbury EA; Gillespie AM; Tidy JA; Smith O; Lawry J; Hancock BW; Wells M
    Histopathology; 2001 May; 38(5):409-17. PubMed ID: 11422477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
    Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
    Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
    Lurain JR
    Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy.
    Uberti EM; Fajardo Mdo C; Ferreira SV; Pereira MV; Seger RC; Moreira MA; Torres MD; de Nápoli G; Schmid H
    Gynecol Oncol; 2009 Dec; 115(3):476-81. PubMed ID: 19818481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The concept of benign metastasizing hydatidiform moles.
    Ring AM
    Am J Clin Pathol; 1972 Aug; 58(2):111-7. PubMed ID: 4340101
    [No Abstract]   [Full Text] [Related]  

  • 51. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydatidiform mole in Kandang Kerbau Hospital--a 5-year review.
    Chong CY; Koh CF
    Singapore Med J; 1999 Apr; 40(4):265-70. PubMed ID: 10487081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
    Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
    Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for gestational trophoblastic disease in Italy.
    La Vecchia C; Franceschi S; Parazzini F; Fasoli M; Decarli A; Gallus G; Tognoni G
    Am J Epidemiol; 1985 Mar; 121(3):457-64. PubMed ID: 2990199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
    Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
    Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of 309 cases after hydatidiform mole: different follow-up program according to biologic behavior.
    Bolis G; Belloni C; Bonazzi C; Mangili G; Presti M; Zanaboni F; Mangioni C
    Tumori; 1988 Feb; 74(1):93-6. PubMed ID: 2451334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical characteristics and management of gestational trophoblastic disease in women aged 50 years or more].
    Feng FZ; Xiang Y; Wan XR; Yin SJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):605-8. PubMed ID: 16202316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
    Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
    Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.